Increase in proteins involved in mitochondrial fission, mitophagy, proteolysis and antioxidant response in type I endometrial cancer as an adaptive response to respiratory complex I deficiency

Biochemical and Biophysical Research Communications

Volumn 491, Issue 1, 2017, Pages 85-90

  Cormio, Antonella ^a   Musicco, Clara ^b   Gasparre, Giuseppe ^c   Cormio, Gennaro ^a,d   Pesce, Vito ^a   Sardanelli, Anna Maria ^a,e   Gadaleta, Maria Nicola ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

ALR; BNIP3; CLPP; Complex I deficiency; Endometrial carcinoma; Mitochondrial dynamics

Indexed keywords

ACTIN; ALR PROTEIN; DRP1 PROTEIN; ENDOPEPTIDASE CLP; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; MITOFUSIN 2; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BNIP3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; TUMOR PROTEIN;

ADAPTIVE IMMUNITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CANCER CELL; COMPLEX I DEFICIENCY; CONTROLLED STUDY; DNA MUTATIONAL ANALYSIS; DOWN REGULATION; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MITOCHONDRIAL DYNAMICS; MITOPHAGY; PRECANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UPREGULATION; DEFICIENCY; ENDOMETRIUM TUMOR; GENETICS; METABOLISM; MITOCHONDRION; PATHOLOGY; TUMOR CELL CULTURE;

ANTIOXIDANTS; ELECTRON TRANSPORT COMPLEX I; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL PROTEINS; NEOPLASM PROTEINS; PROTEOLYSIS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 85023623074     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.07.047     Document Type: Article

References (47)

1. Hecht, J.L., Mutter, G.L., Molecular and pathologic aspects of endometrial carcinogenesis. J. Clin. Oncol. 24 (2006), 4783–4791.
2. Cormio, A., Guerra, F., Cormio, G., et al. The PGC-1alpha-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer. Biochem. Biophys. Res. Commun. 390 (2009), 1182–1185.
3. Guerra, F., Kurelac, I., Cormio, A., et al. Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma. Hum. Mol. Genet. 20 (2011), 2394–2405.
4. Mishr, P., Chan, D.C., Metabolic regulation of mitochondrial dynamics. J. Cell Biol. 212 (2016), 379–387.
5. Chang, C.R., Blackstone, C., Drp1 phosphorylation and mitochondrial regulation. EMBO Rep. 8 (2007), 1088–1089.
6. Corrado, M., Scorrano, L., Campello, S., Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases. Int. J. Cell Biol., 2012, 2012, 729290.
7. Ferreira-da-Silva, A., Valacca, C., Rios, E., et al. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration. PLoS One, 10, 2015, e0122308.
8. Twig, G., Elorza, A., Molina, A.J., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27 (2008), 433–446.
9. Arnoult, D., Rismanchi, N., Grodet, A., et al. Bax/Bak-dependent release of DDP/TIMM8a promotes Drp1-mediated mitochondrial fission and mitoptosis during programmed cell death. Curr. Biol. 15 (2005), 2112–2118.
10. Gomes, L.C., Di Benedetto, G., Scorrano, L., During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 13 (2011), 589–598.
11. Chourasia, A.H., Macleod, K.F., Tumor suppressor functions of BNIP3 and mitophagy. Autophagy 11 (2015), 1937–1938.
12. Rambold, A.S., Kostelecky, B., Elia, N., Lippincott-Schwartz, J., Tubular network formation protects mitochondrial from autophagosomal degradation during nutrient starvation. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10190–10195.
13. Zhang, J., Ney, P.A., Role of BNIP3 and NIX in cell death, autophagy and mitophagy. Cell Death Diff 16 (2009), 939–946.
14. Chinnadurai, G., Vijayalingam, S., Gibson, S.B., BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene 27 (2009), S114–S127.
15. Zhang, J., Ney, P.A., Role of BNIP3 and NIX in cell death, autophagy and mitophagy. Cell Death Diff 16 (2009), 939–946.
16. Bota, D.A., Davies, K.J., Mitochondrial Lon protease in human disease and aging: including an etiologic classification of Lon-related diseases and disorders. Free Radic. Biol. Med. 100 (2016), 188–198.
17. Hamon, M.P., Bulteau, A.L., Friguet, B., Mitochondrial proteases and protein quality control in ageing and longevity. Ageing Res. Rev. 23 (2015), 56–66.
18. Gandhi, R.C., Augmenter of liver regeneration. Fibrogenesis Tissue Repair 5 (2012), 10–27.
19. Polimeno, L., Rossi, R., Mastrodonato, M., et al. Augmenter of liver regeneration, a protective factor against ROS-induced oxidative damage in muscle tissue of mitochondrial myopathy affected patients. Int. J. Biochem. Cell Biol. 45 (2013), 2410–2419.
20. Polimeno, L., Pesetti, B., Lisowsky, T., et al. Protective effect of augmenter of liver regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radic. Res. 43 (2009), 865–875.
21. Polimeno, L., Capuano, F., Marangi, L.C., et al. The augmenter of liver regeneration induces mitochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mitochondria. Dig. Liver Dis. 32 (2000), 510–517.
22. Calvaruso, M.A., Smeitink, J., Nijtmans, L., Electrophoresis techniques to investigate defects in oxidative phosphorylation. Methods 46 (2008), 280–286.
23. Musicco, C., Cormio, A., Calvaruso, M.A., et al. Analysis of the mitochondrial proteome of cybrid cells harbouring a truncative mitochondrial DNA mutation in respiratory complex I. Mol. Biosyst. 10 (2014), 1313–1319.
24. Cormio, A., Guerra, F., Cormio, G., et al. Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium. BMC Res. Notes, 5, 2012, e279.
25. Cormio, A., Cormio, G., Musicco, C., et al. Mitochondrial changes in endometrial carcinoma: possible role in tumor diagnosis and prognosis. Oncol. Rep. 33 (2015), 1011–1018.
26. Pejić, S., Todorović, A., Stojiljković, V., et al. Superoxide dismutase and lipid hydroperoxides in blood and endometrialtissue of patients with benign, hyperplastic and malignant endometrium. An. Acad. Bras. Cienc 80 (2008), 515–522.
27. Kim, B., Song, Y.S., Mitochondrial dynamics altered by oxidative stress in cancer. Free Radic. Res. 50 (2016), 1065–1070.
28. Benard, G., Trian, T., Bellance, N., et al. Adaptative capacity of mitochondrial biogenesis and of mitochondrial dynamics in response to pathogenic respiratory chain dysfunction. Antioxid. Redox Signal 19 (2013), 350–365.
29. Senft, D., Ronai, Z.A., Regulators of mitochondrial dynamics in cancer. Curr. Opin. Cell Biol. 39 (2016), 43–52.
30. Jin, B., Fu, G., Pan, H., et al. Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma. Med. Oncol. 28 (2011), S373–S380.
31. Wang, W., Lu, J., Zhu, F., et al. Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells. Med. Oncol. 29 (2012), 70–76.
32. Rehman, J., Zhang, H.J., Toth, P.T., et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J. 26 (2012), 2175–2186.
33. Kannan, A., Wells, R.B., Sivakumar, S., et al. Mitochondrial reprogramming regulates breast cancer progression. Clin. Cancer Res. 22 (2016), 3348–3360.
34. Zhao, J., Zhang, J., Yu, M., et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 32 (2013), 4814–4824.
35. Kashatus, J.A., Nascimento, A., Myers, L.J., et al. Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth. Mol. Cel. 57 (2015), 537–551.
36. Serasinghe, M.N., Wieder, S.Y., Renault, T.T., et al. Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors. Mol. Cell. 57 (2015), 521–536.
37. Guo, X., Chen, K.H., Guo, Y., et al. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ. Res. 101 (2007), 1113–1122.
38. Inoue-Yamauchi, A., Oda, H., Depletion of mitochondrial fission factor DRP1 causes increased apoptosis in human colon cancer cells. Biochem. Biophys. Res. Commun. 421 (2012), 81–85.
39. Tan, E.Y., Campo, L., Han, C., et al. BNIP3 as a progression marker in primary human breast cancer; opposing functions in situ versus invasive cancer. Clin. Cancer Res. 13 (2007), 467–474.
40. Hu, Y.L., DeLay, M., Jahangiri, A., Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res. 7 (2012), 1773–1783.
41. Springer, M.Z., Macleod, K.F., In brief: mitophagy: mechanisms and role in human disease. J. Pathol. 240 (2016), 253–255.
42. Chourasia, A.H., Tracy, K., Frankenberger, C., et al. Mitophagy defects arising from BNip3 loss promote tumor progression to metastasis. EMBO Rep. 16 (2015), 1145–1163.
43. Gibellini, L., Pinti, M., Bartolomeo, R., et al. Inhibition of Lon protease by triterpenoids alters mitochondria and is associated to cell death in human cancer cells. Oncotarget 6 (2015), 25466–25468.
44. Seo, J.H., Rivadeneira, D.B., Caino, M.C., et al. The mitochondrial unfoldase-peptidase complex ClpXP controls bioenergetics stress and metastasis. PLoS Biol., 14, 2016, e1002507.
45. Cole, A., Wang, Z., Coyaud, E., et al. Inhibition of the mitochondrial protease ClpP as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell. 27 (2015), 864–876.
46. Fuzio, P., Valletti, A., Napoli, A., et al. Regulation of the expression of CLU isoforms in endometrial proliferative diseases. Int. J. Oncol. 42 (2013), 1929–1944.
47. Gatzidou, E., Mantzourani, M., Giaginis, C., et al. Augmenter of liver regeneration gene expression in human colon cancer cell lines and clinical tissue samples., 20, 2015, 84–91.